Last10K.com

Celgene Corp (CELG) SEC Filing 8-K Material Event for the period ending Friday, March 8, 2019

Celgene Corp

HISTORY TOOLS
CIK: 816284 Ticker: CELG

View differences made from one to another to evaluate Celgene Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Celgene Corp.

Continue

Assess how Celgene Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Celgene Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Celgene Corp provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: CELG
CIK: 816284
Form Type: 8-K Corporate News
Accession Number: 0001144204-19-013079
Submitted to the SEC: Fri Mar 08 2019 5:01:07 PM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Friday, March 8, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Regulated Disclosure

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/celg/0001144204-19-013079.htm